D-20133 is an orally active Hexadecylphosphocholine analog. D-20133 can both enhance and inhibit antigen-induced histamine release. D-20133 shows antineoplastic activity against small DMBA (HY-W011845)-induced mammary carcinomas[1][2].
Molecular Weight:
475.69
CAS Number:
[146764-26-3]
Formula:
C26H54NO4P
Target:
Drug Derivative,Histamine Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted